PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

38,389 stories, page 249 of 640

Advanced search
🌍discoverynews.google.comTier 3 · Aggregated media

Class action filed against Aardvark Therapeutics over safety issues and FDA clinical hold on drug trial.

PluangOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Recon: FDA approves Zenbexus for multiple myeloma; NSAI seeks buyer for its MDR notified body business

RAPSOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Asia-Pacific Roundup: Saudi FDA streamlines rare disease drug development

RAPSOriginal source
🌍Regulatoryacrpnet.orgTier 1 · Regulatory source

A Visit with Toni Willis, Public Member of ACRP’s Board of Trustees

ACRP AssociationOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Rockville's AbelZeta Reclaims Its CAR-T Lymphoma Drug From Janssen, Then Immediately Wins FDA Clearance to Test It

BioBuzzOriginal source
🇺🇸Devicesorthopediatrics.comTier 1 · Company source

VerteGlide™

OrthoPediatricsOriginal source
🇺🇸CDMOveranex.comTier 2 · Direct publisher

Veranex and Sus Clinicals Announce Strategic Collaboration to Advance Medical Device Research

VeranexOriginal source
🇺🇸CROppd.comTier 2 · Direct publisher

Beyond trial volume: What China’s clinical trial data signal for global development planning

Thermo Fisher PPDOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Regulatory round-up: 17 August 2026

The Pharma LetterOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Fulcrum Therapeutics shuts down, reverse-merges with N.C. biotech Slate

The Business JournalsOriginal source
🇩🇪Researchfraunhofer.deTier 2 · Direct publisher

Christoph Igel Joins Fraunhofer FKIE’s Institute Management

Fraunhofer Life SciencesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

BioCytics and LIDE Biotech partner to validate immune cell therapies in patient-derived tumor models

AllSciOriginal source
🇺🇸Research5amventures.comTier 2 · Direct publisher

Skye Bioscience and Redx Pharma Announce Transaction Agreement and $125 Million in Financings

5AM VenturesOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Adult social care provider statistics, England: quarterly update to November 2026

Official statistics on the number of people receiving adult social care services, and information on...

UK Department of Health and Social CareOriginal source
🌍Industrydarebioscience.comTier 1 · Company source

DARE-HPV: Potential First-in-Category Treatment for Persistent High-Risk HPV Infection*

Dare BioscienceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Kelun-Biotech H1 2026 presentation: commercialization revenue surges 112%

Investing.comOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Biotech’s reverse merger renaissance poised to continue

Endpoints NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Bombay High Court Orders FDA to Pay ?5 Lakh to Pune Sweet Shop Over Unlawful License Suspension

AD HOC NEWSOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA Eases Approval Path for Certain Cancer Companion Diagnostic Tests

savingadvice.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Could the US Reshore Generics?

Pharmaceutical CommerceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Rat Found in Blinkit Ice Cream Freezer in Thane, Sparks Food Safety Alarm

Deccan ChronicleOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

EyePoint Stock Plummets on Mixed Primary Data From Blindness Drug Study

TradingViewOriginal source
🇺🇸Regulatoryfda.govTier 1 · Regulatory source

American Regent, Inc. Issues Voluntary Nationwide Recall of One Lot of Papaverine Hydrochloride Injection, USP 60 mg/ 2 mL Due to the Presence of Visible Particulate Matter

FDA Drug Safety CommunicationsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Guggenheim Names Top Stock Pick in Biotech Sector

Investing.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA Finalizes Guidance for Assessing Human Health Risks of Antimicrobial Use in Food-Producing Animals

Food Safety MagazineOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

EyePoint Pharmaceuticals (EYPT) Stock Plummets 71% Following Phase 3 Trial Disappointment

BlockonomiOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

UBS raises Cullinan Oncology stock price target to $27 on trial data

Investing.comOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Summit, Akeso’s China approval celebration cut short as survival benefit degrades

BioSpaceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Teva Pharmaceutical’s stock is near its yearly high; is it still a buy?

Investing.comOriginal source
🇺🇸Regulatoryfda.govTier 1 · Regulatory source

Sunny Pharmtech, Inc. Issues Voluntary Nationwide Recall of Cyclophosphamide for Injection, USP to the User Level Due to the Presence of Particulate Matter

FDA Drug Safety CommunicationsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Mesoblast shares jump as Phase 3 chronic back pain trial completes patient treatment

Yahoo FinanceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

EYPT Looks 4000.0% Overvalued on GF Value™ After Phase 3 Setback

GuruFocusOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Biden’s Instagram-to-doorstep abortions are still happening

Washington ExaminerOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Earnings call transcript: Kelun-Biotech H1 2026 profit rises as sales shift to drugs

Investing.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Trinity Biotech's Trinovium, Echelon to Collaborate on Data Center Liquid Cooling

marketscreener.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Barclays Forecasts Strong Price Appreciation for BioMarin Pharmaceutical (NASDAQ:BMRN) Stock

MarketBeatOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Akeso and Summit’s lung cancer drug shows worsening tumor-progression benefit

statnews.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Should Value Investors Buy Takeda Pharmaceutical Co. (TAK) Stock?

Yahoo FinanceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Binghamton SOPPS welcomes new class, faculty and, opportunities

Binghamton UniversityOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Modeling & Simulation: Why Adoption Stalls in Pharmaceutical Development and Manufacturing

Contract PharmaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Moving from conversation to action on women’s health

The Pharmaceutical JournalOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Pharmalittle: We're reading about an AstraZeneca setback, falling U.S. drug prices, and more

STATOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Mandara Biopharma Launches Their Phase 2/3 Clinical Trial for Alzheimer’s Agitation

natlawreview.comOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Evaxion scraps tumor vaccine to focus on brain cancer candidate

Fierce BiotechOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

AstraZeneca Reports Mixed Lung Cancer Trial Outcomes From Three Pivotal Studies

BenzingaOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Zai Lab and argenx Announce Positive Topline Results from Phase 3 ALKIVIA Trial of Efgartigimod in Autoimmune Myositis

BioSpaceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Sinovac Biotech (SVA) H1 Revenue Growth Highlights Price-to-Sales Valuation Challenges

GuruFocusOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Meet Attovia: The Clinical-Stage Biotech That Aims to Stop Chronic Itch at the Source

24/7 Wall St.Original source
🌍discoverynews.google.comTier 3 · Aggregated media

Dirty Towels, Food From The Floor? Old Video On 5-Star Hotel Hygiene Resurfaces

curlytales.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

One Vaccine, Three Supply Chains: The Hidden Consequences of Splitting MMR

Pharmaceutical CommerceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Fulcrum Therapeutics Merges With Slate in $245M Migraine Biotech Deal

MarketBeatOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Zai Lab and Argenx announce results from Alkivia Phase 3 study

TipRanksOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Genscript Biotech Corporation 2026 Q2 - Results - Earnings Call Presentation (OTCMKTS:GNNSF) 2026-08-17

Seeking AlphaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

argenx (NASDAQ: ARGX) says Phase 3 myositis trial hit its goal

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

AlphaValue/Baader Europe Downgrades Sartorius Stedim Biotech to Add, Lifts PT

marketscreener.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Dogwood to Host Virtual KOL Event to Discuss Halneuron® for the Treatment of Chemotherapy Induced Neuropathic Pain on September 1, 2026

The Manila TimesOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Baylor Genetics hit by cybersecurity attack targeting patient, staff information

Fierce BiotechOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Trinity Biotech (TRIB) makes AI data-center cooling push

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Echelon’s More Than 700 MW in Development Gets a Cooling Collaborator

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Halneuron Has Been Tested on More Than 800 Patients—What’s Next?

Stock TitanOriginal source